Short Interest of The Day: Trillium Therapeutics Incorporated (NASDAQ:TRIL)’s Trend Unknown, Especially After Increased Shorts

November 18, 2016 - By Hazel Jackson   ·   0 Comments

Short Interest of The Day: Trillium Therapeutics Incorporated (NASDAQ:TRIL)’s Trend Unknown, Especially After Increased Shorts

The stock of Trillium Therapeutics Incorporated (NASDAQ:TRIL) registered an increase of 2.17% in short interest. TRIL’s total short interest was 329,200 shares in November as published by FINRA. Its up 2.17% from 322,200 shares, reported previously. With 60,400 shares average volume, it will take short sellers 6 days to cover their TRIL’s short positions. The short interest to Trillium Therapeutics Incorporated’s float is 5.29%. The stock closed at $8.75 during the last session. It is down 22.36% since April 18, 2016 and is downtrending. It has underperformed by 26.79% the S&P500.

More news for Trillium Therapeutics Inc. (NASDAQ:TRIL) were recently published by: Marketwatch.com, which released: “Trillium Therapeutics Inc.” on August 24, 2009. Etfdailynews.com‘s article titled: “Trillium Therapeutics Inc. (TRIL): Finding The Next Blockbuster Biotech Stock” and published on June 23, 2015 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Hazel Jackson


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>